ArticleFrontiers in veterinary science2025
Propolis as an alternative remedy for the treatment of subclinical mastitis in dairy cows.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Subclinical mastitis is a widespread condition in dairy cows, often treated with antibiotics. Due to rising antimicrobial resistance, natural alternatives like propolis are gaining interest. Objectives: To evaluate the antibacterial efficacy of 5 and 10% propolis alginate emulsions in cows with subclinical mastitis and assess their effects on milk quality and systemic biomarkers. Methods: Ten dairy cows diagnosed with subclinical mastitis were divided into two treatment groups (5 and 10% propolis emulsions). Emulsions were administered intramammarily and orally for 5 days. Bacterial load in milk, milk composition, blood biochemical and immunological parameters, phenolic compound profiles, and antioxidant activity were analysed using standard microbiological and biochemical methods. Results: The 5% emulsion reduced bacterial load by 2.27 log CFU/ml, outperforming the 10% emulsion (0.89 log CFU/ml; Conclusion: A 5% propolis alginate emulsion was more effective than the 10% formulation in reducing bacterial counts and improving immunological and biochemical profiles. These findings support propolis as a promising natural alternative for treating subclinical mastitis, warranting further investigation into optimal formulations and long-term safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.